NSCLC-IN-1
NSCLC-IN-1 (Compound A10-2) induces mitophagy and ferroptosis through targeting transmembrane BAX inhibitor motif containing 6 (TMBIM6) . NSCLC-IN-1 induces mitochondrial Ca2+ imbalance, leading to mitochondrial damage. NSCLC-IN-1 reduces intracellular glutathione (GSH), increases the accumulation of lipid peroxides (LPO) and malondialdehyde (MDA) content. NSCLC-IN-1 is a potent anti-NSCLC agent[1].
Product Specifications
UNSPSC
12352005
Target
Ferroptosis; Mitophagy
Type
Reference compound
Related Pathways
Apoptosis; Autophagy
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/nsclc-in-1.html
Solubility
10 mM in DMSO
Smiles
O=C(O[C@H]1C(C)=C[C@]23[C@]1(O)[C@H](O)C(COC(C4=CC=C([N+]([O-])=O)C=C4)=O)=CC(C3=O)([H])[C@@]5([H])[C@@](C5(C)C)(OC(CCCCCCCCCCC)=O)C[C@H]2C)C6=CC=C([N+]([O-])=O)C=C6
Molecular Formula
C46H56N2O13
Molecular Weight
844.94
References & Citations
[1]Wang Y, et al. 13-oxyingenol dodecanoate derivatives induce mitophagy and ferroptosis through targeting TMBIM6 as potential anti-NSCLC agents. Eur J Med Chem. 2024 Apr 15;270:116312.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LC422457 20 µg
Rho GTPase activating protein 24 (ARHGAP24) (NM_001025616) Human Over-expression Lysate
Sign In for Pricing
View Details 